EE+ POEM Archive
New oral analogue to remdesivir is similarly effective to nirmatrelvir-ritonavir for mild to moderate symptomatic COVID-19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "New Oral Analogue to Remdesivir Is Similarly Effective to Nirmatrelvir-ritonavir for Mild to Moderate Symptomatic COVID-19." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315846/all/New_oral_analogue_to_remdesivir_is_similarly_effective_to_nirmatrelvir_ritonavir_for_mild_to_moderate_symptomatic_COVID_19.
New oral analogue to remdesivir is similarly effective to nirmatrelvir-ritonavir for mild to moderate symptomatic COVID-19. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315846/all/New_oral_analogue_to_remdesivir_is_similarly_effective_to_nirmatrelvir_ritonavir_for_mild_to_moderate_symptomatic_COVID_19. Accessed April 20, 2024.
New oral analogue to remdesivir is similarly effective to nirmatrelvir-ritonavir for mild to moderate symptomatic COVID-19. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315846/all/New_oral_analogue_to_remdesivir_is_similarly_effective_to_nirmatrelvir_ritonavir_for_mild_to_moderate_symptomatic_COVID_19
New Oral Analogue to Remdesivir Is Similarly Effective to Nirmatrelvir-ritonavir for Mild to Moderate Symptomatic COVID-19 [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315846/all/New_oral_analogue_to_remdesivir_is_similarly_effective_to_nirmatrelvir_ritonavir_for_mild_to_moderate_symptomatic_COVID_19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - New oral analogue to remdesivir is similarly effective to nirmatrelvir-ritonavir for mild to moderate symptomatic COVID-19
ID - 1315846
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315846/all/New_oral_analogue_to_remdesivir_is_similarly_effective_to_nirmatrelvir_ritonavir_for_mild_to_moderate_symptomatic_COVID_19
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
